Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
publishDate:"[2010 TO 2019]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22Kidney+transplant%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22Kidney+transplant%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=publishDate%3A%22%5B2010+TO+2019%5D%22&lookfor=%22Kidney+transplant%22&type=Subject
PubPharm (998)
1
Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant Recipients : The Effect of Sirolimus Plus Maraviroc on the Expression of Chemokine Receptor 5 (CCR5) and the HIV-1 Viral Reservoir in HIV-Infected Renal Transplant Recipients
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
2
Transplant Antibody-mediated Rejection: Guiding Effective Treatments-1 (TAR:GET-1) : A multicentre randomised controlled trial to assess the safety and efficacy of adding rituximab to standard of care in treating acute antibody-mediated rejection in kidney transplantation (Transplant Antibody-mediated Rejection: Guiding Effective Treatments-1 (TAR:GET-1)) - TAR:GET-1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
3
Phase 3 Study to see if QPI-1002 is effective and safe for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI following Cardiac Surgery : A Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for Acute Kidney Injury (AKI) Following Cardiac Surgery - QPI-1002 Phase 3 AKI
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
4
Transplant Antibody-mediated Rejection: Guiding Effective Treatments-1 (TAR:GET-1) : A multicentre randomised controlled trial to assess the safety and efficacy of adding rituximab to standard of care in treating acute antibody-mediated rejection in kidney transplantation (Transplant Antibody-mediated Rejection: Guiding Effective Treatments-1 (TAR:GET-1)) - TAR:GET-1
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
5
Phase 3 Study to see if QPI-1002 is effective and safe for the Prevention of Acute Kidney Injury in Subjects at High Risk for AKI following Cardiac Surgery : A Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of QPI-1002 for the Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for Acute Kidney Injury (AKI) Following Cardiac Surgery - QPI-1002 Phase 3 AKI
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
6
Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation : A Pharmacogenetic Trial of Tacrolimus Dosing After Pediatric Transplantation
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
7
TRANSFORM is an international 24 months study for new kidney transplant patients comparing 2 medication options (treatment choice decided by chance) to compare the effect of the drug everolimus (Certican) to mycophenolate (myfortic or Cellcept), both in combination with tacrolimus or cyclosporine : A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor vs mycophenolate with standard calcineurin inhibitor in de novo renal transplantation - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM) - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
8
Einfluss von Rituximab-Induktion und Lebendspende auf Immunregulation und Viruskontrolle nach Nierentransplantation - eine prospektive Pilotstudie : Einfluss von Rituximab-Induktion und Lebendspende auf Immunregulation und Viruskontrolle nach Nierentransplantation - eine prospektive Pilotstudie
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
9
Long-term outcomes in immunologically low-risk kidney transplant recipients using tacrolimus. Extension study of: Tacrolimus monotherapy in immunologically low-risk kidney transplant recipients: a pilot randomized-controlled study. : Long-term outcomes in immunologically low-risk kidney transplant recipients using tacrolimus. Extension study of: Tacrolimus monotherapy in immunologically low-risk kidney transplant recipients: a pilot randomized-controlled study. - TACmono long-term.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
10
The influence of CYP3A5 and ABCB1 genotype on the pharmacokinetics of twice daily Tacrolimus and Advagraf - Pharmacogenetics of twice daily Tacrolimus and Advagraf : The influence of CYP3A5 and ABCB1 genotype on the pharmacokinetics of twice daily Tacrolimus and Advagraf - Pharmacogenetics of twice daily Tacrolimus and Advagraf
enthalten in:
WHO International Clinical Trials Registry Platform
| 2019
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[100]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Erscheinungsjahr: 2010-2019
Medienart
998
Aufsätze
998
E-Artikel
998
E-Ressourcen
Zeitschriftentitel
634
WHO International Clinical Trials Registry Plat...
364
ClinicalTrials.gov
Thema
998
610
864
Study Type: Interventional
384
Recruitment Status: Not yet recruiting
373
Recruitment Status: Completed
184
Phase: Phase 4
120
Medical Condition: Kidney Transplantation
114
Study Type: Observational
89
Phase: Phase 3
85
Phase: Phase 2
82
Recruitment Status: Authorised-recruitment may ...
58
Recruitment Status: Unknown status
36
Recruitment Status: Recruiting
34
Medical Condition: Kidney Transplant
33
Recruitment Status: Terminated
22
Phase: Other
21
Phase: Phase 2/Phase 3
20
Medical Condition: Prophylaxis of rejection in ...
19
Kidney Failure, Chronic
17
Kidney Diseases
15
Recruitment Status: Withdrawn
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2010-2019
158
2019
176
2018
149
2017
80
2016
99
2015
53
2014
70
2013
178
2012
24
2011
11
2010
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
968
Englisch
10
Spanisch
10
Unbestimmt
4
Deutsch
2
Finnisch
2
Französisch
2
Italienisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...